Smith M R, Liu Y L, Matthews N T, Rhee S G, Sung W K, Kung H F
Biological Carcinogenesis and Development Program, Program Resources, Inc./DynCorp, National Cancer Institute-Frederick Cancer Research and Development Center, MD 21702-1201.
Proc Natl Acad Sci U S A. 1994 Jul 5;91(14):6554-8. doi: 10.1073/pnas.91.14.6554.
Inositol phospholipid-specific phospholipase C (PLC) is involved in several signaling pathways leading to cellular growth and differentiation. Our previous studies reported the induction of DNA synthesis in quiescent NIH 3T3 cells after microinjection of PLC and the inhibition of serum- or Ras-stimulated DNA synthesis by a mixture of monoclonal antibodies to PLC-gamma 1. In the course of our investigation of anti-PLC-gamma 1 monoclonal antibodies, we found that each antibody exerts different inhibitory effects on the phosphatidylinositol-hydrolyzing activity of PLC-gamma 1 and that the inhibition of enzymatic activity does not correlate with the inhibition of DNA synthesis observed in the microinjection assay. PLC-gamma 1 with defective enzymatic activity was synthesized by substituting phenylalanine for histidine within the PLC-gamma 1 catalytic domain at amino acids 335 and 380, and mutant enzymes were expressed using a vaccinia expression system. The mutant enzymes were purified and microinjected into quiescent NIH 3T3 cells to evaluate their mitogenic activity. A moderate induction of DNA synthesis occurred after injection of mutant PLC-gamma 1. This mitogenic activity was inhibited by an antibody (alpha E 8-4) that does not significantly inhibit PLC-gamma 1 enzyme activity, which indicates that something else has to be inhibited. Furthermore, the partial induction of DNA synthesis observed with mutant PLC-gamma 1 was increased to levels seen with wild-type PLC-gamma 1 by coinjection of mutant PLC-gamma 1 with two second messengers, diacylglycerol and inositol trisphosphate. These results suggest that the mitogenic activity of PLC-gamma 1 does not exclusively result from the enzymatic activity of the lipase and that another activity inherent to the PLC-gamma 1 molecule can also induce DNA synthesis in quiescent cells.
肌醇磷脂特异性磷脂酶C(PLC)参与多种导致细胞生长和分化的信号通路。我们之前的研究报道,在向静止的NIH 3T3细胞显微注射PLC后可诱导DNA合成,而针对PLC-γ1的单克隆抗体混合物可抑制血清或Ras刺激的DNA合成。在我们对抗PLC-γ1单克隆抗体的研究过程中,我们发现每种抗体对PLC-γ1的磷脂酰肌醇水解活性具有不同的抑制作用,并且酶活性的抑制与显微注射实验中观察到的DNA合成抑制不相关。通过将苯丙氨酸替代PLC-γ1催化结构域中第335和380位氨基酸的组氨酸来合成具有缺陷酶活性的PLC-γ1,并使用痘苗表达系统表达突变酶。纯化突变酶并将其显微注射到静止的NIH 3T3细胞中以评估其促有丝分裂活性。注射突变型PLC-γ1后出现了适度的DNA合成诱导。这种促有丝分裂活性被一种对PLC-γ1酶活性没有明显抑制作用的抗体(αE 8-4)所抑制,这表明还必须抑制其他物质。此外,通过将突变型PLC-γ1与两种第二信使二酰基甘油和肌醇三磷酸共同注射,观察到的突变型PLC-γ1对DNA合成的部分诱导增加到了野生型PLC-γ1的水平。这些结果表明,PLC-γ1的促有丝分裂活性并非仅仅源于脂肪酶的酶活性,并且PLC-γ1分子固有的另一种活性也可以在静止细胞中诱导DNA合成。